|  | M/z4276 | M/z4292 | M/z8129 | M/z8941 |
---|---|---|---|---|---|
 | n | Median intensity (IQR) | Median intensity (IQR) | Median intensity (IQR) | Median intensity (IQR) |
ER status | Â | Â | Â | Â | Â |
   Negative | 12 | 15.2 (0.7–70.6) | 18.3 (6.2–48.1) | 26.3 (25.2–28.5) | 39.9 (24.3–57.5) |
   Positive | 35 | 11.0 (3.9–24.3) | 14.5 (8.9–22.9) | 25.7 (17.9–28.2) | 30.5 (24.1–43.4) |
p-value* | 47 | .961 | .696 | .421 | .380 |
PR status | Â | Â | Â | Â | Â |
   Negative | 19 | 7.1 (4.0–29.3) | 10.9 (8.5–30.8) | 26.0 (21.7–27.8) | 31.3 (24.0–43.3) |
   Positive | 28 | 14.6 (1.8–28.2) | 15.4 (6.8–28.7) | 25.8 (19.5–29.6) | 32.1 (24.1–46.7) |
p-value* | 47 | .649 | .696 | .762 | .588 |
Her2/neu expression | Â | Â | Â | Â | Â |
   Negative | 35 | 11.0 (1.9–29.3) | 15.9 (5.6–29.5) | 25.9 (20.5–27.8) | 32.9 (24.1–46.9) |
   Positive | 12 | 9.5 (4.3–66.2) | 11.1 (9.1–43.2) | 26.0 (16.2–29.3) | 29.7 (23.3–41.7) |
p-value* | 47 | .961 | .826 | .751 | .575 |
P53 expression | Â | Â | Â | Â | Â |
   Negative | 18 | 6.5 (1.6–24.3) | 12.7 (5.3–31.3) | 23.7 (17.6–26.8) | 27.1 (17.7–42.6) |
   Positive | 23 | 11.0 (4.7–29.4) | 14.9 (8.9–29.5) | 26.5 (24.8–30.1) | 32.9 (27.8–60.8) |
p-value* | 41 | .599 | .546 | .070 | .172 |
Menopause status | Â | Â | Â | Â | Â |
   Premenopausal | 15 | 7.9 (1.9– 84.3) | 12.2 (10.1–69.2) | 27.6 (22.2–32.7) | 29.0 (22.7–43.3) |
   Postmenopausal | 30 | 10.2 (2.0–25.6) | 14.3 (5.5–29.8) | 25.3 (17.8–26.6) | 32.1 (24.2–45.4) |
p-value* | 45 | .942 | .580 | .030 | .563 |